$15.37
At close: Apr 8 EDT
$15.37
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
NovoCure Insider Trading Activity | NASDAQ:NVCR | Benzinga
Track the latest NovoCure insider trading activity. Stay informed on recent buys, sells, and market impact for NovoCure stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are NovoCure Ltd Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On March 4, 2025, Paravasthu Mukund, the company's CHIEF OPERATING OFFICER sold 250 shares for $18.54 each.
- On March 4, 2025, Weinberg Uri, the company's CHIEF INNOVATION OFFICER sold 268 shares for $18.92 each.
- On March 3, 2025, Leupin Nicolas, the company's CHIEF MEDICAL OFFICER sold 991 shares for $20.02 each.
Ownership Statistics for NovoCure Ltd
Shares Outstanding
109.915M
Insider Shares Owned
10.003M
Insider Percentage Owned
9.10%
Institutional Shares Held
75.522M
Institutional Percentage Held
68.7%
| Mar 04, 2025 | Weinberg Uri | CHIEF INNOVATION OFFICER | -268.00 | $18.92 | -$5.07K | SELL | -0.16% | 166.24K | Mar 03 | View |
| Mar 04, 2025 | Leonard Frank X | EVP, PRES., NOVOCURE ONCOLOGY | -2.53K | $18.54 | -$46.84K | SELL | -1.73% | 143.67K | Mar 03 | View |
| Mar 04, 2025 | Cordova Ashley | CHIEF EXECUTIVE OFFICER | -2.05K | $18.54 | -$38.06K | SELL | -1.00% | 204.00K | Mar 03 | View |
| Mar 04, 2025 | Paravasthu Mukund | CHIEF OPERATING OFFICER | -250.00 | $18.54 | -$4.63K | SELL | -0.85% | 29.17K | Mar 03 | View |
| Mar 03, 2025 | Weinberg Uri | CHIEF INNOVATION OFFICER | -4.64K | $18.75 | -$86.95K | SELL | -2.71% | 166.51K | Feb 28 | View |
| Mar 03, 2025 | Leupin Nicolas | CHIEF MEDICAL OFFICER | -991.00 | $20.02 | -$19.84K | SELL | -1.94% | 50.13K | Feb 27 | View |
| Mar 03, 2025 | Puri Michal Nath | CHIEF HUMAN RESOURCES OFFICER | -1.39K | $20.02 | -$27.77K | SELL | -1.26% | 108.71K | Feb 27 | View |
| Mar 03, 2025 | Leonard Frank X | EVP, PRES., NOVOCURE ONCOLOGY | -15.04K | $19.70 | -$296.26K | SELL | -9.33% | 146.20K | Feb 27 - Feb 28 | View |
| Mar 03, 2025 | Cordova Ashley | CHIEF EXECUTIVE OFFICER | -13.49K | $19.72 | -$266.13K | SELL | -6.15% | 206.06K | Feb 27 - Feb 28 | View |
| Mar 03, 2025 | Paravasthu Mukund | CHIEF OPERATING OFFICER | -2.01K | $19.71 | -$39.69K | SELL | -6.41% | 29.42K | Feb 27 - Feb 28 | View |
| Jan 15, 2025 | Paravasthu Mukund | CHIEF OPERATING OFFICER | -2.16K | $26.81 | -$57.91K | SELL | -6.43% | 31.44K | Jan 11 | View |
| Nov 06, 2024 | Paravasthu Mukund | CHIEF OPERATING OFFICER | 30.09K | $16.69 | -$734.18 | GRANT | 859.09% | 33.60K | Nov 02 - Nov 04 | View |
| Nov 04, 2024 | Puri Michal Nath | CHIEF HUMAN RESOURCES OFFICER | -810.00 | $15.79 | -$12.79K | SELL | -0.73% | 110.09K | Oct 31 | View |
| Nov 04, 2024 | Leonard Frank X | EVP, PRES., NOVOCURE ONCOLOGY | -598.00 | $15.94 | -$9.53K | SELL | -0.37% | 161.24K | Nov 01 | View |
| Nov 04, 2024 | Paravasthu Mukund | CHIEF OPERATING OFFICER | -160.00 | $15.88 | -$2.54K | SELL | -4.37% | 3.50K | Nov 01 | View |
| Aug 05, 2024 | Cordova Ashley | CHIEF FINANCIAL OFFICER | -688.00 | $20.14 | -$13.86K | SELL | -0.31% | 219.18K | Aug 02 | View |
| Jun 06, 2024 | Vernon, W. Anthony | — | 3.09K | $23.89 | -$23.03K | GRANT | 1.85% | 169.85K | Jun 04 - Jun 05 | View |
| Jun 06, 2024 | Scannell Timothy J | — | 3.09K | $23.89 | -$23.03K | GRANT | 63.14% | 7.98K | Jun 04 - Jun 05 | View |
| Jun 06, 2024 | Leung Gabriel | — | 3.09K | $23.89 | -$23.03K | GRANT | 3.86% | 83.19K | Jun 04 - Jun 05 | View |
| Mar 05, 2024 | Groenhuysen Wilhelmus CM | CHIEF OPERATING OFFICER | -3.32K | $16.02 | -$53.25K | SELL | -1.31% | 251.24K | Mar 01 - Mar 04 | View |
| Mar 05, 2024 | Leonard Frank X | EVP, PRES., NOVOCURE ONCOLOGY | -2.52K | $16.02 | -$40.36K | SELL | -1.55% | 160.10K | Mar 01 - Mar 04 | View |
| Feb 29, 2024 | Leonard Frank X | EVP, PRES., NOVOCURE ONCOLOGY | 100.17K | $16.22 | $1.63M | GRANT | 160.41% | 162.62K | Feb 27 - Feb 28 | View |
| Feb 29, 2024 | Groenhuysen Wilhelmus CM | CHIEF OPERATING OFFICER | 44.73K | $16.22 | $729.52K | GRANT | 21.32% | 254.56K | Dec 31 - Feb 28 | View |
| Nov 08, 2023 | Pritesh Shah | CHIEF GROWTH OFFICER | -382.00 | $12.65 | -$4.83K | SELL | -0.31% | 124.51K | Nov 07 | View |
| Sep 05, 2023 | Cordova Ashley | CHIEF FINANCIAL OFFICER | -883.00 | $21.82 | -$19.26K | SELL | -0.88% | 99.65K | Sep 01 | View |
| Sep 05, 2023 | Groenhuysen Wilhelmus CM | CHIEF OPERATING OFFICER | -294.00 | $21.82 | -$6.41K | SELL | -0.14% | 209.82K | Sep 01 | View |
| Sep 05, 2023 | Pritesh Shah | CHIEF GROWTH OFFICER | -273.00 | $21.82 | -$5.96K | SELL | -0.22% | 124.89K | Sep 01 | View |
| Aug 04, 2023 | Cordova Ashley | CHIEF FINANCIAL OFFICER | -1.14K | $30.25 | -$34.61K | SELL | -1.13% | 100.53K | Aug 02 | View |
| Mar 07, 2023 | Leonard Frank X | PRESIDENT, CNS CANCERS US | -13.61K | $75.55 | -$1.03M | SELL | -20.04% | 54.28K | Mar 03 - Mar 07 | View |
| Mar 07, 2023 | Pritesh Shah | CHIEF GROWTH OFFICER | -21.42K | $76.16 | -$1.63M | SELL | -14.65% | 124.80K | Mar 03 | View |
| Mar 07, 2023 | Groenhuysen Wilhelmus CM | CHIEF OPERATING OFFICER | -25.64K | $76.16 | -$1.95M | SELL | -10.89% | 209.75K | Mar 03 | View |
| Mar 07, 2023 | Cordova Ashley | CHIEF FINANCIAL OFFICER | -5.50K | $76.16 | -$419.26K | SELL | -5.15% | 101.31K | Mar 03 | View |
| Mar 07, 2023 | Burke William Patrick | CHIEF HUMAN RESOURCES OFFICER | -593.00 | $76.16 | -$45.16K | SELL | -0.89% | 66.09K | Mar 03 | View |
| Mar 06, 2023 | Burke William Patrick | CHIEF HUMAN RESOURCES OFFICER | -281.00 | $75.28 | -$21.15K | SELL | -0.42% | 66.68K | Mar 02 | View |
| Mar 06, 2023 | Pritesh Shah | CHIEF GROWTH OFFICER | 46.24K | $75.28 | -$70.54K | GRANT | 46.26% | 146.22K | Mar 02 - Mar 03 | View |
| Mar 06, 2023 | Groenhuysen Wilhelmus CM | CHIEF OPERATING OFFICER | 50.77K | $75.28 | -$91.31K | GRANT | 27.50% | 235.39K | Mar 02 - Mar 03 | View |
| Mar 06, 2023 | Cordova Ashley | CHIEF FINANCIAL OFFICER | 10.75K | $75.28 | -$79.42K | GRANT | 11.19% | 106.81K | Mar 02 - Mar 03 | View |
| Mar 06, 2023 | Leonard Frank X | PRESIDENT, CNS CANCERS US | 8.90K | $76.95 | -$223.39K | GRANT | 15.10% | 67.89K | Mar 02 - Mar 03 | View |
| Mar 03, 2023 | Leonard Frank X | PRESIDENT, CNS CANCERS US | -4.11K | $75.38 | -$309.58K | SELL | -6.51% | 58.99K | Mar 02 | View |
| Mar 02, 2023 | Frank X Leonard | PRESIDENT, CNS CANCERS US | 16.94K | $76.36 | -$128.59K | GRANT | 36.69% | 63.09K | Feb 28 - Mar 01 | View |
| Mar 02, 2023 | Pritesh Shah | CHIEF GROWTH OFFICER | 17.13K | $76.36 | -$146.84K | GRANT | 20.68% | 99.97K | Feb 28 - Mar 01 | View |
| Mar 02, 2023 | Ashley Cordova | CHIEF FINANCIAL OFFICER | 21.62K | $76.36 | -$167.84K | GRANT | 29.04% | 96.06K | Feb 28 - Mar 01 | View |
| Mar 02, 2023 | William Patrick Burke | CHIEF HUMAN RESOURCES OFFICER | 11.37K | $76.36 | -$57.65K | GRANT | 20.45% | 66.96K | Feb 28 - Mar 01 | View |
| Mar 02, 2023 | Wilhelmus CM Groenhuysen | CHIEF OPERATING OFFICER | 19.49K | $76.36 | -$165.25K | GRANT | 11.80% | 184.62K | Feb 28 - Mar 01 | View |
| Jan 09, 2023 | Uri Weinberg | CHIEF SCIENCE OFFICER | -6.20K | $81.59 | -$854.22K | SELL | -12.52% | 43.29K | Jan 05 | View |
| Jan 09, 2023 | Frank X Leonard | PRESIDENT, CNS CANCERS US | -4.30K | $63.82 | -$3.89M | SELL | -8.52% | 46.16K | Jan 05 | View |
| Jan 09, 2023 | Pritesh Shah | CHIEF COMMERCIAL OFFICER | -387.00 | $108.00 | -$41.80K | SELL | -0.46% | 82.84K | Jan 05 | View |
| Jan 09, 2023 | Asaf Danziger | CHIEF EXECUTIVE OFFICER | 39.00 | $58.20 | -$21.48M | SELL-OPTIONS | 0.29% | 13.62K | Jan 05 - Jan 06 | View |
| Oct 17, 2022 | Frank X Leonard | PRESIDENT, CNS CANCERS US | -6.75K | $76.01 | -$513.37K | SELL | -13.41% | 43.63K | Oct 13 | View |
| Oct 07, 2022 | Frank X Leonard | PRESIDENT, CNS CANCERS US | -6.75K | $84.37 | -$569.83K | SELL | -11.82% | 50.38K | Oct 06 | View |
| Sep 30, 2022 | Frank X Leonard | PRESIDENT, CNS CANCERS US | -6.75K | $77.35 | -$522.42K | SELL | -10.57% | 57.13K | Sep 29 | View |
| Sep 26, 2022 | Frank X Leonard | PRESIDENT, CNS CANCERS US | -6.75K | $77.00 | -$520.06K | SELL | -9.56% | 63.89K | Sep 22 | View |
| Sep 19, 2022 | Frank X Leonard | CHIEF DEVELOPMENT OFFICER | -6.75K | $47.83 | -$1.05M | SELL | -8.73% | 70.64K | Sep 15 | View |
| Sep 12, 2022 | Frank X Leonard | CHIEF DEVELOPMENT OFFICER | -1.86K | $88.00 | -$163.94K | SELL | -2.17% | 84.15K | Sep 09 | View |
| Sep 07, 2022 | Frank X Leonard | CHIEF DEVELOPMENT OFFICER | -1.38K | $78.57 | -$108.74K | SELL | -1.58% | 86.01K | Sep 06 | View |
| Sep 06, 2022 | William Patrick Burke | CHIEF HUMAN RESOURCES OFFICER | -718.00 | $79.04 | -$56.75K | SELL | -1.28% | 55.49K | Sep 02 | View |
| Sep 06, 2022 | Ashley Cordova | CHIEF FINANCIAL OFFICER | -885.00 | $79.04 | -$69.95K | SELL | -1.21% | 72.38K | Sep 02 | View |
| Sep 06, 2022 | Wilhelmus CM Groenhuysen | CHIEF OPERATING OFFICER | -296.00 | $79.04 | -$23.39K | SELL | -0.18% | 165.02K | Sep 02 | View |
| Sep 06, 2022 | Pritesh Shah | CHIEF COMMERCIAL OFFICER | -269.00 | $79.04 | -$21.26K | SELL | -0.32% | 83.23K | Sep 02 | View |
| Sep 06, 2022 | Frank X Leonard | CHIEF DEVELOPMENT OFFICER | -14.80K | $77.50 | -$1.15M | SELL | -14.48% | 87.40K | Sep 01 - Sep 02 | View |
| Aug 04, 2022 | Ely Benaim | CHIEF MEDICAL OFFICER | -5.96K | $73.73 | -$439.33K | SELL | -17.21% | 28.67K | Aug 03 | View |
| Aug 03, 2022 | William F Doyle | EXECUTIVE CHAIRMAN | -837.00 | $69.66 | -$58.30K | SELL | -0.15% | 551.18K | Aug 02 | View |
| Aug 03, 2022 | Ely Benaim | CHIEF MEDICAL OFFICER | -437.00 | $69.66 | -$30.44K | SELL | -1.25% | 34.63K | Aug 02 | View |
| Aug 03, 2022 | Frank X Leonard | CHIEF DEVELOPMENT OFFICER | -414.00 | $69.66 | -$28.84K | SELL | -0.40% | 102.19K | Aug 02 | View |
| Jun 16, 2022 | Jeryl L Hilleman | DIRECTOR | -407.00 | $69.61 | -$28.33K | SELL | -13.82% | 2.54K | Jun 10 | View |
| May 12, 2022 | Ely Benaim | CHIEF MEDICAL OFFICER | -4.21K | $63.17 | -$265.65K | SELL | -10.77% | 34.85K | May 10 - May 11 | View |
| Mar 11, 2022 | Pritesh Shah | CHIEF COMMERCIAL OFFICER | 48.00 | $112.60 | $311.26K | SELL-OPTIONS | 0.06% | 83.19K | Jul 31 - Mar 09 | View |
| Mar 09, 2022 | Pritesh Shah | CHIEF COMMERCIAL OFFICER | -7.78K | $69.73 | -$542.12K | SELL | -8.67% | 81.91K | Mar 07 - Mar 08 | View |
| Mar 09, 2022 | Frank X Leonard | CHIEF DEVELOPMENT OFFICER | -744.00 | $70.10 | -$52.15K | SELL | -0.72% | 102.30K | Mar 08 | View |
| Mar 09, 2022 | William Patrick Burke | CHIEF HUMAN RESOURCES OFFICER | -1.04K | $70.10 | -$72.69K | SELL | -1.82% | 55.99K | Mar 08 | View |
| Mar 09, 2022 | Wilhelmus CM Groenhuysen | CHIEF OPERATING OFFICER | -2.92K | $70.10 | -$204.90K | SELL | -1.74% | 165.10K | Mar 08 | View |
| Mar 09, 2022 | Ashley Cordova | CHIEF FINANCIAL OFFICER | -759.00 | $70.10 | -$53.21K | SELL | -1.23% | 60.85K | Mar 08 | View |
| Mar 09, 2022 | Todd Longsworth | GENERAL COUNSEL | -2.34K | $70.10 | -$163.96K | SELL | -3.61% | 62.46K | Mar 08 | View |
| Mar 09, 2022 | William F Doyle | EXECUTIVE CHAIRMAN | -2.38K | $70.10 | -$167.19K | SELL | -0.43% | 552.01K | Mar 08 | View |
| Mar 07, 2022 | Todd Longsworth | GENERAL COUNSEL | -3.07K | $71.87 | -$220.41K | SELL | -4.52% | 64.80K | Mar 03 - Mar 04 | View |
| Mar 07, 2022 | Ashley Cordova | CHIEF FINANCIAL OFFICER | 19.80K | $73.16 | -$124.74K | GRANT | 47.37% | 61.61K | Mar 03 - Mar 04 | View |
| Mar 07, 2022 | Pritesh Shah | CHIEF COMMERCIAL OFFICER | 16.17K | $72.54 | -$402.06K | GRANT | 22.00% | 89.68K | Mar 03 - Mar 04 | View |
| Mar 07, 2022 | Ely Benaim | CHIEF MEDICAL OFFICER | 15.06K | $71.83 | -$166.14K | GRANT | 53.40% | 43.26K | Mar 03 - Mar 04 | View |
| Mar 07, 2022 | William Patrick Burke | CHIEF HUMAN RESOURCES OFFICER | 6.08K | $71.43 | -$97.64K | GRANT | 11.93% | 57.03K | Mar 03 - Mar 04 | View |
| Mar 07, 2022 | Wilhelmus CM Groenhuysen | CHIEF OPERATING OFFICER | 18.05K | $71.78 | -$277.80K | GRANT | 12.04% | 168.03K | Mar 03 - Mar 04 | View |
| Mar 07, 2022 | Frank X Leonard | CHIEF DEVELOPMENT OFFICER | 15.89K | $72.97 | -$108.36K | GRANT | 18.23% | 103.04K | Mar 03 - Mar 04 | View |
| Jan 05, 2022 | William Patrick Burke | CHIEF HUMAN RESOURCES OFFICER | 24.65K | $43.24 | -$266.98 | SELL-OPTIONS | 94.03% | 50.87K | Jan 03 | View |
| Nov 29, 2021 | Asaf Danziger | CHIEF EXECUTIVE OFFICER | 4.97K | $102.44 | $509.54K | BUY | 59.91% | 13.28K | Nov 26 | View |
| Nov 03, 2021 | Ashley Cordova | CHIEF FINANCIAL OFFICER | -209.00 | $107.28 | -$22.42K | SELL | -0.50% | 41.76K | Nov 02 | View |
| Sep 07, 2021 | Frank X Leonard | CHIEF DEVELOPMENT OFFICER | -540.00 | $138.23 | -$74.65K | SELL | -0.62% | 87.15K | Sep 02 | View |
| Sep 07, 2021 | Ashley Cordova | CHIEF FINANCIAL OFFICER | -828.00 | $138.23 | -$114.46K | SELL | -1.93% | 41.97K | Sep 02 | View |
| Sep 07, 2021 | Wilhelmus CM Groenhuysen | CHIEF OPERATING OFFICER | -181.00 | $138.23 | -$25.02K | SELL | -0.12% | 149.90K | Sep 02 | View |
| Sep 07, 2021 | Pritesh Shah | CHIEF COMMERCIAL OFFICER | -657.00 | $138.57 | -$91.04K | SELL | -0.89% | 73.51K | Sep 02 - Sep 03 | View |
| Aug 16, 2021 | Ashley Cordova | CHIEF FINANCIAL OFFICER | 8.27K | $84.88 | -$2.70M | SELL-OPTIONS | 22.97% | 44.26K | Aug 12 | View |
| Aug 06, 2021 | Martin J Madden | DIRECTOR | -34.00 | $153.13 | -$5.21K | SELL | -0.21% | 16.00K | Aug 05 | View |
| Aug 06, 2021 | Pritesh Shah | CHIEF COMMERCIAL OFFICER | -2.06K | $148.71 | -$306.79K | SELL | -2.71% | 74.17K | Aug 04 | View |
| Aug 06, 2021 | Gabriel Leung | DIRECTOR | 0.00 | $91.97 | -$121.05K | SELL-OPTIONS | 0.00% | 72.86K | Aug 05 | View |
| Aug 04, 2021 | Frank X Leonard | CHIEF DEVELOPMENT OFFICER | -1.04K | $149.39 | -$155.52K | SELL | -1.15% | 89.16K | Aug 02 - Aug 03 | View |
| Aug 04, 2021 | Pritesh Shah | CHIEF COMMERCIAL OFFICER | -1.65K | $149.43 | -$247.16K | SELL | -2.12% | 76.23K | Aug 03 | View |
| Aug 04, 2021 | William F Doyle | EXECUTIVE CHAIRMAN | -995.00 | $149.38 | -$148.63K | SELL | -0.18% | 554.40K | Aug 02 | View |
| Aug 04, 2021 | Ely Benaim | CHIEF MEDICAL OFFICER | -464.00 | $150.11 | -$69.65K | SELL | -1.62% | 28.14K | Aug 03 | View |
| Aug 03, 2021 | Ely Benaim | CHIEF MEDICAL OFFICER | -536.00 | $118.97 | -$129.32K | SELL | -1.84% | 28.61K | Jul 30 - Aug 02 | View |
| Jul 08, 2021 | Gabriel Leung | DIRECTOR | 0.00 | $107.49 | -$152.09K | SELL-OPTIONS | 0.00% | 72.86K | Jul 06 | View |
| Jun 11, 2021 | Pritesh Shah | CHIEF COMMERCIAL OFFICER | -23.54K | $215.00 | -$5.06M | SELL | -23.24% | 77.73K | Jun 10 | View |
| Jun 08, 2021 | Gabriel Leung | DIRECTOR | 0.00 | $118.00 | -$173.10K | SELL-OPTIONS | 0.00% | 72.05K | Jun 07 | View |
| May 28, 2021 | Ely Benaim | CHIEF MEDICAL OFFICER | 0.00 | $123.78 | -$279.42K | SELL-OPTIONS | 0.00% | 29.05K | May 27 | View |
| May 14, 2021 | Ely Benaim | CHIEF MEDICAL OFFICER | -1.94K | $180.48 | -$350.67K | SELL | -6.27% | 29.05K | May 12 | View |
| May 12, 2021 | Ely Benaim | CHIEF MEDICAL OFFICER | -2.26K | $115.97 | -$667.88K | SELL | -6.80% | 31.00K | May 10 - May 11 | View |
| May 12, 2021 | Uri Weinberg | CHIEF SCIENCE OFFICER | -1.80K | $118.61 | -$888.61K | SELL | -5.39% | 31.67K | May 10 | View |
| May 06, 2021 | Pritesh Shah | CHIEF COMMERCIAL OFFICER | -1.29K | $199.67 | -$257.57K | SELL | -1.26% | 101.27K | May 05 | View |
| May 06, 2021 | Gabriel Leung | DIRECTOR | 0.00 | $115.56 | -$168.22K | SELL-OPTIONS | 0.00% | 72.05K | May 05 | View |
| May 05, 2021 | Pritesh Shah | CHIEF COMMERCIAL OFFICER | 1.29K | $202.48 | $266.67K | SELL-OPTIONS | 1.27% | 102.56K | May 03 - May 04 | View |
| Apr 15, 2021 | William F Doyle | EXECUTIVE CHAIRMAN | -95.00K | $199.55 | -$18.96M | SELL | -14.61% | 555.39K | Apr 13 | View |
| Apr 15, 2021 | Asaf Danziger | CHIEF EXECUTIVE OFFICER | -97.97K | $196.34 | -$19.24M | SELL | -92.29% | 8.18K | Apr 13 | View |
| Apr 15, 2021 | Gabriel Leung | DIRECTOR | 0.00 | $115.14 | -$1.00M | SELL-OPTIONS | 0.00% | 72.05K | Apr 13 | View |
| Apr 15, 2021 | Ely Benaim | CHIEF MEDICAL OFFICER | 0.00 | $132.09 | -$809.20K | SELL-OPTIONS | 0.00% | 33.26K | Apr 13 | View |
| Apr 08, 2021 | Wilhelmus CM Groenhuysen | CHIEF OPERATING OFFICER | -3.67K | $72.22 | -$265.03K | SELL | -2.39% | 150.01K | Feb 28 | View |
| Apr 02, 2021 | William F Doyle | EXECUTIVE CHAIRMAN | 1.33K | $129.69 | $96.39K | SELL-OPTIONS | 0.21% | 650.39K | Mar 31 - Apr 01 | View |
| Mar 25, 2021 | Uri Weinberg | CHIEF SCIENCE OFFICER | 0.00 | $93.52 | -$361.80K | SELL-OPTIONS | 0.00% | 36.31K | Mar 23 | View |
| Mar 10, 2021 | Pritesh Shah | CHIEF COMMERCIAL OFFICER | -6.15K | $130.97 | -$805.59K | SELL | -5.73% | 101.27K | Mar 08 - Mar 09 | View |
| Mar 10, 2021 | Ashley Cordova | CHIEF FINANCIAL OFFICER | -765.00 | $130.81 | -$100.07K | SELL | -2.09% | 35.89K | Mar 08 | View |
| Mar 10, 2021 | Todd Longsworth | GENERAL COUNSEL | -2.40K | $130.81 | -$314.46K | SELL | -3.43% | 67.71K | Mar 08 | View |
| Mar 10, 2021 | Frank X Leonard | CHIEF DEVELOPMENT OFFICER | -765.00 | $130.81 | -$100.07K | SELL | -0.84% | 90.05K | Mar 08 | View |
| Mar 10, 2021 | Wilhelmus CM Groenhuysen | CHIEF OPERATING OFFICER | -3.00K | $130.81 | -$392.94K | SELL | -1.92% | 153.68K | Mar 08 | View |
| Mar 09, 2021 | Pritesh Shah | CHIEF COMMERCIAL OFFICER | 9.44K | $69.34 | -$498.45K | SELL-OPTIONS | 9.63% | 107.42K | Mar 05 | View |
| Mar 09, 2021 | Ely Benaim | CHIEF MEDICAL OFFICER | -2.92K | $131.53 | -$383.80K | SELL | -8.07% | 33.26K | Mar 05 | View |
| Mar 08, 2021 | Wilhelmus CM Groenhuysen | CHIEF OPERATING OFFICER | -3.85K | $137.55 | -$530.13K | SELL | -2.40% | 156.69K | Mar 04 | View |
| Mar 08, 2021 | Todd Longsworth | GENERAL COUNSEL | -3.08K | $137.55 | -$424.22K | SELL | -4.21% | 70.12K | Mar 04 | View |
| Mar 08, 2021 | Frank X Leonard | CHIEF DEVELOPMENT OFFICER | -567.00 | $137.55 | -$77.99K | SELL | -0.62% | 90.81K | Mar 04 | View |
| Mar 08, 2021 | Ashley Cordova | CHIEF FINANCIAL OFFICER | -1.48K | $137.55 | -$77.99K | SELL | -3.87% | 36.66K | Mar 04 | View |
| Mar 05, 2021 | Ely Benaim | CHIEF MEDICAL OFFICER | -1.89K | $107.75 | -$542.60K | SELL | -4.96% | 36.18K | Mar 03 - Mar 04 | View |
| Mar 05, 2021 | Pritesh Shah | CHIEF COMMERCIAL OFFICER | -4.83K | $143.50 | -$693.41K | SELL | -4.70% | 97.99K | Mar 03 - Mar 04 | View |
| Mar 04, 2021 | Frank X Leonard | CHIEF DEVELOPMENT OFFICER | 8.28K | $152.05 | -$65.38K | GRANT | 9.96% | 91.38K | Mar 02 | View |
| Mar 04, 2021 | Ashley Cordova | CHIEF FINANCIAL OFFICER | 10.46K | $152.05 | -$65.08K | GRANT | 37.79% | 38.13K | Mar 02 | View |
| Mar 04, 2021 | Wilhelmus CM Groenhuysen | CHIEF OPERATING OFFICER | 10.13K | $152.05 | -$363.71K | GRANT | 6.73% | 160.54K | Mar 02 | View |
| Mar 04, 2021 | Pritesh Shah | CHIEF COMMERCIAL OFFICER | 9.97K | $152.05 | -$138.67K | GRANT | 10.74% | 102.82K | Mar 02 | View |
| Mar 04, 2021 | Todd Longsworth | GENERAL COUNSEL | 7.99K | $152.05 | -$358.08K | GRANT | 12.25% | 73.20K | Mar 02 | View |
| Feb 24, 2021 | Uri Weinberg | CHIEF SCIENCE OFFICER | 0.00 | $91.33 | -$1.09M | SELL-OPTIONS | 0.00% | 27.60K | Feb 22 | View |
| Jan 19, 2021 | Todd Longsworth | GENERAL COUNSEL | -27.42K | $93.43 | -$10.48M | SELL | -31.49% | 59.66K | Jan 15 | View |
| Dec 22, 2020 | Ely Benaim | — | 0.00 | $106.82 | -$247.86K | OPTION EXERCISE | 0.00% | 29.36K | Dec 21 | View |
| Dec 22, 2020 | Jeryl L Hilleman | — | -2.50K | $166.40 | -$416.00K | SELL | -42.37% | 3.40K | Dec 18 | View |
| Dec 22, 2020 | Asaf Danziger | — | 0.00 | $89.69 | -$28.15M | OPTION EXERCISE | 0.00% | 197.63K | Dec 18 | View |
| Nov 03, 2020 | Ashley Cordova | — | -230.00 | $117.41 | -$27.00K | SELL | -0.87% | 26.21K | Nov 02 | View |
| Sep 28, 2020 | Uri Weinberg | — | 0.00 | $56.49 | -$1.43M | OPTION EXERCISE | 0.00% | 27.60K | Sep 25 | View |
| Sep 21, 2020 | Wilhelmus CM Groenhuysen | — | 0.00 | $58.35 | -$840.49K | OPTION EXERCISE | 0.00% | 142.61K | Sep 18 | View |
| Sep 18, 2020 | Wilhelmus CM Groenhuysen | — | 0.00 | $57.58 | -$3.47M | OPTION EXERCISE | 0.00% | 142.61K | Sep 16 - Sep 17 | View |
| Sep 17, 2020 | Asaf Danziger | — | 0.00 | $60.50 | -$7.93M | OPTION EXERCISE | 0.00% | 197.63K | Sep 15 | View |
| Sep 16, 2020 | Gabriel Leung | — | 0.00 | $52.46 | -$1.76M | OPTION EXERCISE | 0.00% | 72.05K | Sep 14 - Sep 15 | View |
| Sep 16, 2020 | Wilhelmus CM Groenhuysen | — | 0.00 | $54.40 | -$7.15M | OPTION EXERCISE | 0.00% | 142.61K | Sep 14 - Sep 15 | View |
| Sep 11, 2020 | Pritesh Shah | — | -28.32K | $85.41 | -$2.42M | SELL | -28.67% | 70.47K | Sep 09 | View |
| Sep 11, 2020 | Gabriel Leung | — | 0.00 | $47.53 | -$1.54M | OPTION EXERCISE | 0.00% | 72.05K | Sep 09 - Sep 10 | View |
| Sep 04, 2020 | Gabriel Leung | — | 0.00 | $46.02 | -$7.80K | OPTION EXERCISE | 0.00% | 72.05K | Sep 02 | View |
| Sep 03, 2020 | Pritesh Shah | — | -2.23K | $85.01 | -$357.05K | GRANT OR AWARD | -2.21% | 98.79K | Sep 01 - Sep 02 | View |
| Aug 27, 2020 | Gabriel Leung | — | 0.00 | $43.58 | -$519.89K | OPTION EXERCISE | 0.00% | 72.05K | Aug 25 | View |
| Aug 05, 2020 | Pritesh Shah | — | -3.72K | $76.63 | -$284.83K | SELL | -3.55% | 101.02K | Aug 03 - Aug 04 | View |
| Aug 05, 2020 | Ely Benaim | — | -660.00 | $76.06 | -$50.20K | SELL | -2.20% | 29.36K | Aug 03 | View |
| Aug 03, 2020 | Ely Benaim | — | -16.00 | $63.40 | -$9.67K | GRANT OR AWARD | -0.05% | 30.02K | Jul 07 - Jul 31 | View |
| Aug 03, 2020 | William F Doyle | — | -896.00 | $76.39 | -$68.44K | SELL | -0.14% | 649.06K | Jul 31 | View |
| Aug 03, 2020 | Gabriel Leung | — | 0.00 | $41.02 | -$483.40K | OPTION EXERCISE | 0.00% | 72.05K | Jul 30 | View |
| Jul 23, 2020 | Michael J Ambrogi | — | 0.00 | $42.71 | -$2.24M | OPTION EXERCISE | 0.00% | 220.87K | Jul 21 - Jul 22 | View |
| Jul 23, 2020 | Gabriel Leung | — | 0.00 | $36.98 | -$599.03K | OPTION EXERCISE | 0.00% | 72.05K | Jul 21 - Jul 22 | View |
| May 14, 2020 | Ely Benaim | — | -2.60K | $64.78 | -$168.10K | SELL | -17.06% | 12.62K | May 12 | View |
| May 12, 2020 | Ely Benaim | — | 2.60K | $63.78 | $165.85K | OPTION EXERCISE | 20.57% | 15.21K | May 08 - May 11 | View |
| May 12, 2020 | William F Doyle | — | -31.33K | $63.73 | -$2.00M | SELL | -4.60% | 649.96K | May 11 | View |
| May 11, 2020 | William F Doyle | — | 54.64K | $64.21 | $3.53M | OPTION EXERCISE | 8.72% | 681.29K | May 07 - May 08 | View |
| May 07, 2020 | Pritesh Shah | — | -1.15K | $62.20 | -$71.47K | SELL | -1.13% | 100.69K | May 05 | View |
| May 07, 2020 | William F Doyle | — | 57.37K | $63.07 | $3.57M | OPTION EXERCISE | 10.08% | 626.65K | May 05 - May 06 | View |
| May 05, 2020 | Pritesh Shah | — | 1.15K | $62.94 | $82.38K | OPTION EXERCISE | 1.14% | 101.84K | May 01 - May 04 | View |
| Apr 15, 2020 | Michael J Ambrogi | — | 0.00 | $38.63 | -$3.68M | OPTION EXERCISE | 0.00% | 220.87K | Apr 13 - Apr 14 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.